Generation Bio Co. vs Moderna, Inc.
Market value, revenue, profit, valuation and financial strength side by side, each from the company's own filings or market data, with its date.
In short
- Moderna, Inc. is the larger company by market value: $90.1 B against $126 M for Generation Bio Co., 715 times as much (market caps of Jan 5, 2024 for Generation Bio Co. and Oct 30, 2026 for Moderna, Inc.). Generation Bio Co.'s value is the last on file, from Jan 5, 2024: no market-data feed is connected for its exchange yet.
- Both made a net loss: $80 M for Generation Bio Co. and $2.8 B for Moderna, Inc.
- Moderna, Inc. employs more people: 4,700 against 85 at Generation Bio Co.
Market value, the same start = 100
From Jan 2021: how each one's value moved, whatever its size.
Revenue by fiscal year
US$ billions, as reported in each year's annual results.
Side by side
| Measure | Generation Bio Co. GBIO | Moderna, Inc. MRNA · #275 in the world |
|---|---|---|
| Profile | ||
| Country | 🇺🇸 USA | 🇺🇸 USA |
| Sector | Healthcare | Healthcare |
| Industry | Biotechnology | Biotechnology |
| Founded | — | 2010 |
| Size | ||
| Market cap | $126 M* | $90.1 B |
| Revenue | $0 M | $1.9 B |
| Net income | $-81 M▲ best | $-2.8 B |
| Employees | 85 | 4,700 |
| Valuation | ||
| Price to sales | — | 35.7× |
| Price to book | — | 10.4× |
| Free cash flow yield | — | -2.3% |
| Profitability | ||
| Gross margin | — | 55.4% |
| Operating margin | — | -158.1% |
| Net margin | — | -145.2% |
| Return on equity | — | -28.9% |
| Growth | ||
| Revenue growth | — | -39.9% |
| Revenue growth, 3 years a year | — | -53.4% |
| Financial strength | ||
| Debt to equity | — | 0.1× |
| Cash | ||
| Free cash flow margin | — | -106.2% |
| Shareholder returns | ||
| Shareholder yield | — | 0.0% |
| Strength scores | ||
| Piotroski F-score | — | 3 of 9 |
| Altman Z-score zone | — | safe |
| Data as of | Market cap Jan 2024 | Market cap Oct 2026; ratios FY2025 |
Questions and answers#
Which is bigger, Generation Bio Co. or Moderna, Inc.?
Moderna, Inc. is the larger company by market value: $90.1 B against $126 M for Generation Bio Co., 715 times as much (market caps of Jan 5, 2024 for Generation Bio Co. and Oct 30, 2026 for Moderna, Inc.). Generation Bio Co.'s value is the last on file, from Jan 5, 2024: no market-data feed is connected for its exchange yet.
Which makes more money, Generation Bio Co. or Moderna, Inc.?
Both made a net loss: $80 M for Generation Bio Co. and $2.8 B for Moderna, Inc.
Which has more employees, Generation Bio Co. or Moderna, Inc.?
Moderna, Inc. employs more people: 4,700 against 85 at Generation Bio Co.